Director Zach Scheiner resigns from LENZ Therapeutics board; Jeff George appointed to audit committee

LENZ Therapeutics, Inc.

Zach Scheiner resigned from the Board and all committees effective June 30, 2026.
Resignation was not due to any dispute or disagreement with the company.
Board size reduced from seven to six members following the resignation.
Jeff George appointed to Audit Committee; members now Thunen, Guerard, and George.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.